StockData
Penumbra Inc logo

Penumbra Inc (PEN) stock

PENNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 15/3074% above fair value
$319.11−1.51 (-0.47%)

Close on Nov 17, 2026Market cap $12.58BP/E 80.4Yield –

Penumbra price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Penumbra's price to sales ratio was 8.4× on Nov 11, 2026, against 8.7× a year earlier. Over the last 5 years it ranged from 6.0× to 15.2×, with a median of 8.7×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20268.4×−0.8
2025Dec 31, 20259.2×+1.3
2024Dec 31, 20248.0×−1.9
2023Dec 29, 20239.9×−0.3
2022Dec 30, 202210.2×−5.0
2021Dec 31, 202115.2×+3.5
2020Dec 31, 202011.7×+0.3
2019Dec 31, 201911.4×+1.0
2018Dec 31, 201810.3×+0.4
2017Dec 29, 201710.0×+1.3
2016Dec 30, 20168.6×−1.0
2015Dec 31, 20159.6×–

More Penumbra figures

See a number that looks wrong?